Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Thursday 19 March 2020 4:32 pm

Coronavirus: US looks to approve new treatments as cases pass 10,000

By: Edward Thicknesse

Add as a preferred source on Google
asian stocks

US president Donald Trump has announced that anti-malaria drug hydroxychloroquine will be made available almost immediately to treat coronavirus, as the number of cases in the US passed 10,000. 

The drug is one of a number of therapies that the US Food and Drug Administration (FDA) is investigating as possible treatments for the virus.

Trump said that the treatment could be a “game-changer” in the fight against coronavirus, and hailed the work being done by the FDA to combat the disease:

“For the FDA to act so fast is an incredible thing… it’s a very exciting time for medicine”, he said. 

The White House’s coronavirus task force coordinator Dr Deborah Birx said that 10 per cent of tests for the virus were coming back positive.

She added that 50 per cent of all cases in the US came from just 10 counties. 

US authorities have been focused on amping up the number of tests conducted, with New York governor Andrew Cuomo saying the state tested nearly 8,000 people overnight.

Read more

GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

GSK said total sales fell by two per cent in the third quarter

Sign up to City PM’s Midday Update newsletter, delivered to your inbox every lunchtime

In a wide-ranging press conference, the president said that the virus was “too bad, because we have never had an economy as we had a few weeks ago”.

He was, however, bullish on the future of the economy, saying that it would “be back”:

“It’s going to go up very rapidly [once the crisis is over]… back to where we were and beyond”. 

Trump also highlighted his role in pulling together an emergency aid package for workers and business, saying that he had “slashed red tape like never before” to get the measures in place.

Despite hailing the bipartisan spirit on Capitol Hill, he could not resist another jibe at the expense of China, saying:

“If people had known about [the disease], it could have been stopped where it came from… China”.

Read more

GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Related Topics

  • Coronavirus
  • International

Trending Articles

  • Burnham tax plans spark investor rush to bank capital gains

  • Nothing fails to file accounts months after dissolution threat

  • I’ve taken the best train trips in the world. Here are my 5 favourites

  • Cruyff turn: Starmer allows pubs to stay open for England World Cup game

  • Nottingham Forest owner Marinakis announces £210m stadium plans

More from City PM

  • GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

    Tech
    GSK said total sales fell by two per cent in the third quarter
  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Peace deal will be finalised Sunday, Trump says but Tehran casts doubt

    Politics
    Donald Trump at Pennsylvania CPA event, addressing financial policies to an audience of accounting professionals
  • As it happened: Stocks mixed as Trump warns takes ‘two to tango’ on Iran peace

    Markets
    Donald Trump at Pennsylvania CPA event, addressing financial policies to an audience of accounting professionals
  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • Regulator wins decade-long pricing tussle with Pfizer

    Legal
    Hikma reported a jump in profit for 2024
  • Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

    Business Wire
  • Trump blocked from sacking Fed official in landmark Supreme Court ruling

    Politics

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy